| Literature DB >> 27586369 |
Hua-Yin Li1,2, Bang-Dang Chen1,2, Yi-Tong Ma3,4, Yi-Ning Yang1,2, Xiang Ma1,2, Fen Liu2, Zhen-Yan Fu1,2, Xiang Xie1,2, Xiao-Mei Li1,2, Shuo Pan1,2, Chun-Hui He1,2, Ying-Ying Zheng1,2, Yun Wu1,2, Jing Tao1,2, Chun-Lan Dong1,2, Ting-Ting Wu1,2.
Abstract
BACKGROUND: To determine whether TG/HDL-C ratio, which has been shown to be an indicator of the metabolic syndrome (MetS) and insulin resistance (IR), can predict cardiovascular risk factors in the Chinese Han population in Xinjiang.Entities:
Keywords: Cardiovascular risk factors; Cutoff; Han adults; TG/HDL ratio; Xinjiang
Mesh:
Substances:
Year: 2016 PMID: 27586369 PMCID: PMC5025992 DOI: 10.1186/s41043-016-0067-8
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
Age-standardized cardiovascular disease risk factors in the Chinese Han men by TG/HDL-C category
| TG/HDL-C ≤ 0.5 | 0.5 < TG/HDL-C ≤1.0 | 1.0 < TG/HDL-C ≤1.5 | 1.5 < TG/HDL-C ≤2.0 | 2.0 < TG/HDL-C ≤2.5 | TG/HDL-C > 2.5 |
| |
|---|---|---|---|---|---|---|---|
| Men | |||||||
| Population distribution (%) | 460 (16.5 %) | 639 (22.9 %) | 536 (19.2 %) | 398 (14.3 %) | 253 (9.1 %) | 502 (18.0 %) | |
| Age (years) | 52.64 ± 13.20 | 53.99 ± 13,94 | 53.54 ± 13.96 | 51.71 ± 12.74 | 50.27 ± 12.30 | 49.44 ± 12.01 | <0.001 |
| Systolic blood pressure (mmHg) | 133.19 ± 19.69 | 132.92 ± 19.35 | 133.91 ± 17.67 | 135.99 ± 17.93 | 134.60 ± 18.43 | 136.92 ± 18.56 | <0.001 |
| Diastolic blood pressure (mmHg) | 86.00 ± 15.14 | 85.13 ± 14.80 | 86.86 ± 14.59 | 88.87 ± 15.19 | 87.89 ± 15.35 | 90.36 ± 15.39 | <0.001 |
| Total cholesterol (mmol/L) | 4.13 ± 1.13 | 4.42 ± 0.99 | 4.68 ± 0.95 | 4.81 ± 0.93 | 4.92 ± 0.99 | 5.15 ± 1.10 | <0.001 |
| HDL cholesterol (mmol/L) | 1.60 ± 0.50 | 1.39 ± 0.39 | 1.24 ± 0.36 | 1.15 ± 0.36 | 1.10 ± 0.36 | 0.93 ± 0.37 | <0.001 |
| LDL cholesterol (mmol/L) | 3.07 ± 0.83 | 3.03 ± 0.91 | 2.83 ± 0.84 | 2.79 ± 0.81 | 2.76 ± 0.88 | 2.63 ± 0.94 | <0.001 |
| Triglycerides (mmol/L) | 1.17 ± 1.47 | 1.02 ± 0.30 | 1.55 ± 0.49 | 1.99 ± 0.62 | 2.47 ± 0.83 | 3.95 ± 2.61 | <0.001 |
| Fasting glucose (mmol/L) | 5.15 ± 1.68 | 5.23 ± 1.93 | 5.39 ± 1.68 | 5.45 ± 1.40 | 5.55 ± 1.70 | 6.05 ± 2.66 | <0.001 |
| BMI (kg/m2) | 25.07 ± 3.21 | 24.97 ± 3.44 | 25.92 ± 3.09 | 26.08 ± 3.03 | 26.07 ± 2.81 | 26.63 ± 3.24 | <0.001 |
TG/HDL-C triglycerides/high-density lipoprotein cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, BMI body mass index
Age-standardized cardiovascular disease risk factors in the Chinese Han women by TG/HDL-C category
| TG/HDL-C ≤ 0.5 | 0.5 < TG/HDL-C ≤1.0 | 1.0 < TG/HDL-C ≤1.5 | 1.5 < TG/HDL-C ≤2.0 | 2.0 < TG/HDL-C ≤2.5 | TG/HDL-C > 2.5 |
| |
|---|---|---|---|---|---|---|---|
| Women | |||||||
| Population distribution (%) | 607 (20.4 %) | 988 (33.3 %) | 520 (17.5 %) | 358 (12.1 %) | 220 (7.4 %) | 276 (9.3 %) | |
| Age (years) | 48.65 ± 11.51 | 51.34 ± 12.11 | 54.40 ± 11.99 | 55.81 ± 11.64 | 56.71 ± 11.90 | 56.34 ± 11.25 | <0.001 |
| Systolic blood pressure (mmHg) | 123.97 ± 18.67 | 128.27 ± 20.33 | 133.87 ± 20.97 | 135.88 ± 20.42 | 139.69 ± 21.42 | 139.11 ± 20.68 | <0.001 |
| Diastolic blood pressure (mmHg) | 78.96 ± 15.93 | 81.59 ± 15.08 | 83.79 ± 15.55 | 86.07 ± 15.52 | 84.52 ± 15.57 | 87.77 ± 15.16 | <0.001 |
| Total cholesterol (mmol/L) | 4.22 ± 1.09 | 4.52 ± 0.96 | 4.88 ± 0.97 | 5.00 ± 0.99 | 5.05 ± 1.28 | 5.23 ± 1.24 | <0.001 |
| HDL cholesterol (mmol/L) | 1.64 ± 0.60 | 1.36 ± 0.36 | 1.21 ± 0.33 | 1.08 ± 0.33 | 0.97 ± 0.31 | 0.85 ± 0.34 | <0.001 |
| LDL cholesterol (mmol/L) | 3.06 ± 0.95 | 3.06 ± 0.95 | 2.73 ± 0.82 | 2.71 ± 0.89 | 2.66 ± 0.85 | 2.56 ± 0.88 | <0.001 |
| Triglycerides (mmol/L) | 0.85 ± 0.78 | 0.99 ± 0.28 | 1.50 ± 0.42 | 1.86 ± 0.57 | 2.15 ± 0.68 | 3.39 ± 2.27 | <0.001 |
| Fasting glucose (mmol/L) | 4.88 ± 1.12 | 5.02 ± 1.51 | 5.30 ± 1.46 | 5.46 ± 1.80 | 5.56 ± 1.88 | 5.77 ± 2.03 | <0.001 |
| BMI (kg/m2) | 23.53 ± 3.26 | 24.00 ± 3.62 | 25.21 ± 3.77 | 25.22 ± 3.49 | 25.89 ± 3.39 | 25.86 ± 3.45 | <0.001 |
TG/HDL-C triglycerides/high-density lipoprotein cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, BMI body mass index
Age-standardized prevalence of risk factors in the Chinese Han men by TG/HDL-C category
| TG/HDL-C ≤ 0.5 (%) | 0.5 < TG/HDL-C ≤1.0 (%) | 1.0 < TG/HDL-C ≤1.5 (%) | 1.5 < TG/HDL-C ≤2 (%) | 2.0 < TG/HDL-C ≤2.5 (%) | TG/HDL-C > 2.5 (%) |
| |
|---|---|---|---|---|---|---|---|
| Men | |||||||
| Hypertension | 34.60 | 37.80 | 42.20 | 46.40 | 35.50 | 47.00 | <0.001 |
| Diabetes | 4.90 | 5.50 | 9.30 | 9.00 | 8.30 | 17.10 | <0.001 |
| Hypercholesterolemia | 16.70 | 17.40 | 28.00 | 32.20 | 36.80 | 44.00 | <0.001 |
| High LDL cholesterol | 48.00 | 42.90 | 36.60 | 35.30 | 34.00 | 28.30 | <0.001 |
| Low HDL cholesterol | 10.90 | 12.80 | 31.70 | 43.70 | 50.60 | 65.10 | <0.001 |
| Hypertriglyceridemia | 15.30 | 3.30 | 29.70 | 63.10 | 82.60 | 94.40 | <0.001 |
TG/HDL-C triglycerides/high-density lipoprotein cholesterol
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma glucose ≥7.0 mmol/L and/or current diabetes drug use. Hypercholesterolemia was defined as TC ≥ 6.22 mmol/L, high LDL cholesterol was defined as LDL-C ≥ 4.14 mmol/L, low HDL cholesterol was defined as HDL-C < 1.04 mmol/L, and hypertriglyceridemia was defined as TG ≥ 2.26 mmol/L
Age-standardized prevalence of risk factors in the Chinese Han women by TG/HDL-C category
| TG/HDL-C ≤ 0.5 (%) | 0.5 < TG/HDL-C ≤1.0 (%) | 1.0 < TG/HDL-C ≤1.5 (%) | 1.5 < TG/HDL-C ≤2 (%) | 2.0 < TG/HDL-C ≤2.5 (%) | TG/HDL-C > 2.5 (%) |
| |
|---|---|---|---|---|---|---|---|
| Women | |||||||
| Hypertension | 21.60 | 32.00 | 41.80 | 48.30 | 51.40 | 55.00 | <0.001 |
| Diabetes | 3.20 | 4.70 | 8.30 | 9.80 | 8.60 | 13.80 | <0.001 |
| Hypercholesterolemia | 15.70 | 21.40 | 36.00 | 40.50 | 45.00 | 49.30 | <0.001 |
| High LDL cholesterol | 44.30 | 43.40 | 28.50 | 28.50 | 30.60 | 25.40 | <0.001 |
| Low HDL cholesterol | 7.60 | 15.10 | 35.00 | 52.20 | 62.30 | 73.60 | <0.001 |
| Hypertriglyceridemia | 7.40 | 1.50 | 26.30 | 54.70 | 66.80 | 87.70 | <0.001 |
TG/HDL-C triglycerides/high-density lipoprotein cholesterol
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma glucose ≥7.0 mmol/L and/or current diabetes drug use. Hypercholesterolemia was defined as TC ≥ 6.22 mmol/L, high LDL cholesterol was defined as LDL-C ≥ 4.14 mmol/L, low HDL cholesterol was defined as HDL-C < 1.04 mmol/L, and hypertriglyceridemia was defined as TG ≥ 2.26 mmol/L
Sensitivity (Sens), specificity (Spec), and distance in the receiver operating characteristic (ROC) curvefor TG/HDL-C cutoffs in the Chinese Han men
| Hypertension | Dyslipidemia | Diabetes | ≥2 risk factors | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TG/HDL-C cutoffs | Percentile | Sens | Spec | Distance in ROC curve | Sens | Spec | Distance in ROC curve | Sens | Spec | Distance in ROC curve | Sens | Spec | Distance in ROC curve |
| Men | % | % | % | % | |||||||||
| 0.5 | 9.1 | 0.89 | 0.15 | 0.85 | 0.98 | 0.24 | 0.76 | 0.92 | 0.15 | 0.86 | 0.97 | 0.16 | 0.84 |
| 0.6 | 13.8 | 0.85 | 0.22 | 0.79 | 0.96 | 0.33 | 0.67 | 0.88 | 0.20 | 0.81 | 0.95 | 0.23 | 0.77 |
| 0.7 | 18.3 | 0.80 | 0.30 | 0.73 | 0.94 | 0.44 | 0.57 | 0.85 | 0.27 | 0.75 | 0.94 | 0.30 | 0.70 |
| 0.8 | 24.0 | 0.76 | 0.35 | 0.69 | 0.92 | 0.52 | 0.49 | 0.81 | 0.32 | 0.71 | 0.91 | 0.36 | 0.65 |
| 0.9 | 28.1 | 0.71 | 0.39 | 0.67 | 0.90 | 0.59 | 0.42 | 0.77 | 0.37 | 0.67 | 0.89 | 0.41 | 0.60 |
| 1.0 | 32.1 | 0.67 | 0.44 | 0.65 | 0.88 | 0.66 | 0.37 | 0.74 | 0.42 | 0.64 | 0.86 | 0.46 | 0.56 |
| 1.1 | 36.6 | 0.63 | 0.49 | 0.64 | 0.85 | 0.72 | 0.32 | 0.70 | 0.46 | 0.62 | 0.83 | 0.51 | 0.52 |
| 1.2 | 40.0 | 0.59 | 0.52 | 0.63 | 0.82 | 0.77 | 0.29 | 0.66 | 0.50 | 0.61 | 0.80 | 0.55 | 0.49 |
| 1.3 | 43.9 | 0.55 | 0.56 |
| 0.79 | 0.82 |
| 0.62 | 0.54 | 0.60 | 0.77 | 0.60 | 0.47 |
| 1.4 | 47.5 | 0.50 | 0.60 | 0.64 | 0.74 | 0.85 | 0.30 | 0.57 | 0.58 |
| 0.71 | 0.64 |
|
| 1.5 | 51.4 | 0.46 | 0.64 | 0.65 | 0.69 | 0.88 | 0.34 | 0.53 | 0.62 | 0.60 | 0.67 | 0.67 | 0.47 |
| 1.6 | 55.1 | 0.42 | 0.67 | 0.67 | 0.64 | 0.91 | 0.37 | 0.49 | 0.66 | 0.61 | 0.63 | 0.70 | 0.48 |
| 1.7 | 57.9 | 0.39 | 0.69 | 0.68 | 0.61 | 0.92 | 0.40 | 0.47 | 0.68 | 0.62 | 0.59 | 0.73 | 0.49 |
| 1.8 | 60.8 | 0.35 | 0.72 | 0.71 | 0.56 | 0.95 | 0.44 | 0.43 | 0.72 | 0.64 | 0.54 | 0.76 | 0.52 |
| 1.9 | 63.6 | 0.32 | 0.73 | 0.73 | 0.53 | 0.96 | 0.48 | 0.40 | 0.74 | 0.66 | 0.50 | 0.78 | 0.55 |
| 2.0 | 65.5 | 0.31 | 0.74 | 0.74 | 0.50 | 0.96 | 0.50 | 0.38 | 0.75 | 0.66 | 0.48 | 0.79 | 0.56 |
The cutoff for dyslipidemia and hypertension was 1.3 and for diabetes and ≥2 risk factors was 1.4
Sensitivity (Sens), specificity (Spec), and distance in the receiver operating characteristic (ROC) curve for TG/HDL-C cutoff in the Chinese Han women
| Hypertension | Dyslipidemia | Diabetes | ≥2 risk factors | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TG/HDL-C cutoffs | Percentile | Sens | Spec | Distance in ROC curve | Sens | Spec | Distance in ROC curve | Sens | Spec | Distance in ROC curve | Sens | Spec | Distance in ROC curve |
| Women | % | % | % | % | % | ||||||||
| 0.5 | 14.5 | 0.85 | 0.26 | 0.75 | 0.94 | 0.30 | 0.70 | 0.89 | 0.22 | 0.79 | 0.97 | 0.25 | 0.75 |
| 0.6 | 21.8 | 0.79 | 0.36 | 0.68 | 0.90 | 0.41 | 0.60 | 0.84 | 0.31 | 0.71 | 0.92 | 0.34 | 0.67 |
| 0.7 | 29.6 | 0.72 | 0.44 | 0.62 | 0.86 | 0.51 | 0.51 | 0.78 | 0.39 | 0.65 | 0.88 | 0.43 | 0.59 |
| 0.8 | 37.0 | 0.65 | 0.54 | 0.58 | 0.82 | 0.62 | 0.42 | 0.72 | 0.47 | 0.60 | 0.84 | 0.52 | 0.51 |
| 0.9 | 43.3 | 0.60 | 0.59 |
| 0.79 | 0.69 | 0.38 | 0.67 | 0.52 | 0.58 | 0.82 | 0.58 | 0.46 |
| 1.0 | 47.6 | 0.55 | 0.64 | 0.58 | 0.76 | 0.74 |
| 0.63 | 0.57 |
| 0.77 | 0.63 | 0.44 |
| 1.1 | 51.7 | 0.51 | 0.68 | 0.59 | 0.71 | 0.78 | 0.37 | 0.58 | 0.62 | 0.57 | 0.74 | 0.67 |
|
| 1.2 | 55.1 | 0.47 | 0.71 | 0.61 | 0.67 | 0.81 | 0.38 | 0.54 | 0.65 | 0.58 | 0.70 | 0.71 | 0.42 |
| 1.3 | 59.0 | 0.43 | 0.74 | 0.63 | 0.63 | 0.84 | 0.41 | 0.49 | 0.68 | 0.60 | 0.65 | 0.74 | 0.44 |
| 1.4 | 62.0 | 0.39 | 0.77 | 0.65 | 0.58 | 0.87 | 0.44 | 0.46 | 0.71 | 0.62 | 0.61 | 0.77 | 0.46 |
| 1.5 | 65.3 | 0.36 | 0.80 | 0.68 | 0.53 | 0.89 | 0.48 | 0.42 | 0.75 | 0.64 | 0.56 | 0.80 | 0.48 |
| 1.6 | 68.1 | 0.32 | 0.82 | 0.70 | 0.49 | 0.91 | 0.52 | 0.39 | 0.78 | 0.65 | 0.52 | 0.82 | 0.51 |
| 1.7 | 70.9 | 0.29 | 0.84 | 0.73 | 0.45 | 0.92 | 0.56 | 0.35 | 0.80 | 0.68 | 0.49 | 0.85 | 0.54 |
| 1.8 | 73.4 | 0.26 | 0.86 | 0.75 | 0.40 | 0.94 | 0.60 | 0.32 | 0.83 | 0.70 | 0.44 | 0.87 | 0.57 |
| 1.9 | 75.9 | 0.23 | 0.90 | 0.77 | 0.37 | 0.95 | 0.64 | 0.29 | 0.85 | 0.73 | 0.40 | 0.89 | 0.61 |
| 2.0 | 77.5 | 0.22 | 0.88 | 0.79 | 0.35 | 0.95 | 0.65 | 0.28 | 0.85 | 0.73 | 0.39 | 0.89 | 0.62 |
The cutoff for dyslipidemia and diabetes was 1.0, for hypertension was 0.9, and for ≥2 risk factors was 1.1
Fig. 1ROC curves to detect CVD risk factors by sex. a ROC curves for both men and women for the detection of hypertension, b dyslipidemia, c diabetes, and d ≥2 of these risk factors